我要投票 伊可新在鱼肝油行业中的票数:241
· 外 推 电 报 ·
2025-04-21 16:53:46 星期一

【伊可新是哪个国家的品牌?】

伊可新是什么牌子?「伊可新」是 山东达因海洋生物制药股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人张璨在1994-10-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力伊可新品牌出海!通过在本页面挂载伊可新品牌的产品链接和联系邮箱,可以提高伊可新产品曝光!跨境电商爆单神器,目前只要100元/年哦~

“伊可新”属维生素类非处方药药品,宝宝出生15天开始,每天一粒,能有效预防和治疗维生素A及D的缺乏症,维生素d缺乏会引起佝偻病、小儿手足抽搐症,免疫力下降等,维生素A缺乏会引起机体免疫功能下降,易感性增加,腹泻和呼吸道感染发病率显著增加,还可增加缺铁性贫血发生率。伊可新有两种规格满足不同年龄宝宝每日营养所需,绿色伊可新(绿葫芦)适合0-1岁的宝宝,粉色伊可新(粉葫芦)适合1岁以上的宝宝;伊可新采用先进工艺、最佳科学配比保障了维生素AD的有效吸收,其精确的每天一粒剂量,以及香甜口味,是妈妈们放心的选择。

产品简介

药理作用:本品由维生素A及维生素D组成。维生素A和D是人体生长发育必需的物质,胎儿、婴幼儿的发育尤为重要,对保证上皮组织的完整性、视力、生殖器官、血钙和磷的恒定、骨骼、牙齿的生长发育等有重要作用,同时与机体的免疫功能也密切相关。

适应症:用于预防和治疗维生素A及D的缺乏症。如佝偻病、夜盲症及小儿手足抽搐症,可以促进钙吸收,增强抵抗力。

产品规格:0-1岁(绿色包装)每粒含1500国际单位维生素A,500国际单位维生素D3;1岁以上(红色包装)每粒含2000国际单位维生素A,700国际单位维生素D3。
用量用法

口服。将软囊滴嘴开口后,内容物滴入婴儿口中(开口方法:建议采用将滴嘴在开水中浸泡30秒,使胶皮融化;或采用干净的专用小剪子)。胶囊皮为可食用医用明胶制成,家长可根据孩子吞咽和咀嚼能力的情况,嚼服胶丸。1次1粒,1日1次。

山东达因海洋生物制药股份有限公司成立于1994年10月,是省级高新技术企业,主要从事儿童用药的研发、生产和销售,注册地在山东省荣成市。下设全资子公司北京达因康健医药有限责任公司和山东达因生物科技有限公司。

公司主要股东为山大华特科技股份有限公司、荣成市公有资产经营有限公司和中国医学科学院医药生物技术研究所等。其中山大华特科技股份有限公司是山东大学控股的山东省高校唯一上市公司(股票代码000915)。

公司现有产品主要涉及儿童药品和儿童保健食品领域,初步形成了以“儿童保健和治疗”为核心的儿童健康产业格局。儿童药品有伊可新(维生素AD滴剂胶囊型)、盖笛欣(复方碳酸钙泡腾颗粒剂)、伊甘欣(甘草锌颗粒剂)、右旋糖酐铁口服液等;儿童食品有益生菌粉、牛初乳咀嚼片、乳酸亚铁冲剂等。同时,公司产品还涉及内分泌、心血管、消化系统及抗感染等领域用药。

公司生产基地位于山东省荣成市开发区,占地300余亩,拥有软胶囊、硬胶囊、颗粒剂、片剂、口服液等多条现代化生产线及原料药车间。公司注重新产品、新技术研发和投入,积极开展省级研发平台建设,通过产学研合作,不断提高技术创新水平,以专业和责任捍卫儿童用药安全。

公司管理总部设在北京,销售网络遍及全国。在经营实践中,始终坚持“创新成就品牌,专业运作市场”的专业化推广方式,打造出了一支专业化素质高、执行力强的优秀团队,在业内赢得了广泛好评,多次获得省级荣誉称号。2010年达因®获山东省著名商标,旗下明星产品伊可新(维生素AD滴剂胶囊型)年销量突破4亿元、连续13年位居同类产品市场占有率第一。公司的销售收入、利润总额,根据2012年工信部公布的《中国医药统计年报》统计,位于全国化学制药工业前200强行列。

公司在取得良好经营业绩的同时,多年来一直积极参与社会公益和慈善事业,通过出资建设“达因希望小学”、参与西部贫困地区“我要上学”大型助学活动,以及向灾区、特困儿童等持续捐赠等多种形式回报社会,不断践行着达因人“使千千万万中国儿童健康强壮”的使命。


英文翻译:"Yi Ke Xin" is a kind of vitamin non prescription medicine. Starting from birth 15 days, hair coloring can effectively prevent and treat vitamin A and D deficiency. Vitamin D deficiency can cause rickets, infantile hand foot convulsion and immunity decline. Vitamin A deficiency can cause the decrease of immune function of the machine, increase the susceptibility, and increase the incidence of diarrhea and respiratory tract infection. It can increase the incidence of iron deficiency anemia. Icoxin has two specifications to meet the daily nutrition needs of babies of different ages. Green icoxin (green gourd) is suitable for babies aged 0-1, and pink icoxin (pink gourd) is suitable for babies over 1 year old. Icoxin adopts advanced technology and the best scientific ratio to ensure the effective absorption of vitamin ad. its accurate daily dose and sweet taste are safe choices for mothers 。 Pharmacological action: This product is composed of vitamin A and vitamin D. Vitamin A and vitamin D are essential substances for human growth and development, especially for the development of fetus and infants. They play an important role in ensuring the integrity of epithelial tissue, vision, reproductive organs, the constancy of blood calcium and phosphorus, the growth and development of bones and teeth, and are closely related to the immune function of the body. Indications: used to prevent and treat vitamin A and D deficiency. Such as rickets, night blindness and convulsions in children's hands and feet can promote calcium absorption and enhance resistance. Product specification: 0-1-year-old (green package) contains 1500 international units of vitamin A, 500 international units of vitamin D3; 1-year-old (red package) contains 2000 international units of vitamin A, 700 international units of vitamin D3. Take orally. After opening the mouth of the soft bag dripper, drop the contents into the baby's mouth (opening method: it is recommended to soak the dripper in boiling water for 30 seconds to melt the rubber; or use clean special scissors). The capsule skin is made of edible medical gelatin, and parents can chew and take the capsule according to their children's swallowing and chewing ability. One capsule once a day. Shandong dyne marine biopharmaceutical Co., Ltd. was founded in October 1994. It is a provincial high-tech enterprise, mainly engaged in the research, development, production and sales of children's drugs, registered in Rongcheng City, Shandong Province. It has two wholly-owned subsidiaries, Beijing dyne Health Medicine Co., Ltd. and Shandong dyne Biotechnology Co., Ltd. The main shareholders of the company are sunwater Technology Co., Ltd., Rongcheng City Public Assets Management Co., Ltd. and Institute of pharmaceutical biotechnology, Chinese Academy of Medical Sciences, etc. Shanda Huate Technology Co., Ltd. is the only listed company (Stock Code: 000915) in Shandong Province, which is controlled by Shandong University. The company's existing products mainly involve children's medicine and children's health food, and has initially formed a children's health industry pattern with "children's health care and treatment" as the core. Children's medicines include ikosin (vitamin AD drop capsule), gedixin (compound calcium carbonate effervescent granules), iganxin (Glycyrrhiza zinc granules), dextran iron oral liquid, etc.; children's food includes probiotic powder, Bovine Colostrum Chewable Tablets, ferrous lactate granules, etc. At the same time, the company's products are also involved in endocrine, cardiovascular, digestive system and anti infection and other fields. The company's production base is located in Rongcheng Development Zone, Shandong Province, covering an area of more than 300 mu, with a number of modern production lines and API workshops such as soft capsule, hard capsule, granule, tablet, oral liquid, etc. The company pays attention to the research and development and investment of new products and technologies, actively carries out the construction of provincial research and development platform, continuously improves the level of technological innovation through the cooperation of production, education and research, and defends the safety of children's drug use with professional and responsibility. The company is headquartered in Beijing, with sales network throughout the country. In the business practice, we always adhere to the professional promotion mode of "innovation makes brand, professional operation market", and have created an excellent team with high professional quality and strong execution, which has won wide praise in the industry and won provincial honorary titles for many times. In 2010, dyne ® won the famous trademark of Shandong Province, and its star product icoxin (vitamin AD drops capsule type) has an annual sales volume of more than 400 million yuan, ranking first in the market share of similar products for 13 consecutive years. The total sales revenue and profit of the company are in the top 200 of the national chemical pharmaceutical industry according to the statistics of China Pharmaceutical statistics annual report published by the Ministry of industry and information technology in 2012. While achieving good business performance, the company has been actively participating in social public welfare and philanthropy for many years. By investing in the construction of "dyne hope primary school", participating in large-scale "I want to go to school" learning activities in western poverty-stricken areas, and continuing to donate to the disaster areas, especially poor children and other forms, the company has been constantly practicing "making thousands of Chinese children healthy and strong" Strong "mission.

本文链接: https://www.waitui.com/brand/aa4d7e6ca.html

千城特选小程序码

7×24h 快讯

宁德时代发布钠离子电池 “钠新” 第一款产品,今年6月量产

宁德时代正式发布名为“钠新”的钠离子电池,并推出了第一款产品宁德时代纳新24V重卡启驻一体蓄电池,今年6月正式量产。据透露,宁德时代的钠离子电池可以在多面挤压、针刺贯穿、电钻穿透和电池锯断等实验之下,做到“不起火、不爆炸”。(财联社)

54分钟前

俄经济部将2025年布伦特油价预测下调近17%

俄罗斯国际文传电讯社4月21日早些时候报道,俄罗斯经济部已将其对2025年布伦特原油平均价格预测较去年9月时下调近17%,从每桶81.7美元下调至每桶68美元。(新华社)

54分钟前

佳能EOS青年影像学院暨第三届佳能大学生影像节在西安开幕

36氪获悉,4月17日,佳能※1“EOS青年影像学院”全国系列活动首站暨第三届大学生影像节在西安开幕。陕西省摄影家协会主席冯晓伟及秘书长杨洪波、佳能(中国)有限公司华北区域总部首席代表王川出席活动。据了解,本次活动吸引了西安电子科技大学、西北大学、长安大学、陕西师范大学、西北工业大学、西安交通大学六所高校超过500名大学生摄影爱好者参与。本届“佳能大学生影像节”线上征集活动已于4月15日开放,为青年创作者提供交流展示平台。

54分钟前

人民银行王信:航运、化工等7个行业转型金融标准正在研制

人民银行研究局局长王信4月21日在国新办新闻发布会上表示,人民银行牵头制定了钢铁、煤电、建材、农业4个重点行业转型金融标准工作取得重要进展。“我们还制定了使用说明,对转型主体的认定条件予以明确,以有效满足传统高碳领域在低碳转型过程中合理必要的资金需求。”王信称,目前这几项标准正在部分地区试用,而且受到市场普遍欢迎。王信透露,第二批航运、化工等7个行业转型金融标准研制工作正在进行。(中国网)

54分钟前

减重版司美格鲁肽中国说明书更新,纳入心血管获益结果

从诺和诺德了解到,中国国家药品监督管理局(NMPA)批准更新诺和盈(减重版司美格鲁肽2.4mg)的说明书。此次更新基于SELECT(司美格鲁肽在超重或肥胖患者中的心血管结局试验)的主要结果:在超重或肥胖且已确诊心血管疾病不伴有糖尿病的成人患者中,诺和盈可降低主要不良心血管事件(MACE,包括心血管死亡、非致死性心肌梗死、非致死性卒中)发生风险达20%。(澎湃)

54分钟前

本页详细列出关于仔力奇的品牌信息,含品牌所属公司介绍,仔力奇所处行业的品牌地位及优势。
咨询